Tradename | Company | Number | Date | Products |
---|---|---|---|---|
XENAZINE | Bausch Health Companies | N-021894 RX | 2008-08-15 | 2 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
tetrabenazine | ANDA | 2024-11-25 |
xenazine | New Drug Application | 2022-06-22 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
huntington disease | Orphanet_399 | D006816 | G10 |
hyperkinesis | — | D006948 | — |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Tourette syndrome | D005879 | EFO_0004895 | F95.2 | — | 1 | — | — | — | 1 |
Syndrome | D013577 | — | — | — | 1 | — | — | — | 1 |
Drug common name | Tetrabenazine |
INN | tetrabenazine |
Description | 9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one is a benzoquinolizine that is 1,2,3,4,4a,9,10,10a-octahydrophenanthrene in which the carbon at position 10a is replaced by a nitrogen and which is substituted by an isobutyl group at position 2, an oxo group at position 3, and methoxy groups at positions 6 and 7. It is a benzoquinolizine, a cyclic ketone and a tertiary amino compound. ... More |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COc1cc2c(cc1OC)C1CC(=O)C(CC(C)C)CN1CC2 |
PDB | — |
CAS-ID | 58-46-8 |
RxCUI | — |
ChEMBL ID | CHEMBL117785 |
ChEBI ID | 64028 |
PubChem CID | 6018 |
DrugBank | DB04844 |
UNII ID | Z9O08YRN8O (ChemIDplus, GSRS) |